Neutropenia clinical trials

Explore recruiting neutropenia clinical trials.

Recruiting neutropenia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neutropenia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of mavorixafor in participants with congenital and acquired primary autoimmune and idiopathic chronic neutropenic disorders who are experiencing recurrent and/or serious infections.

Spain, Hungary, Germany, Czechia, Romania, France +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and Safety Clinical Trial for Immune-Guided Prevention of CMV Infection in Low-Risk Kidney Transplantation. (INMUNOVIR Study)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multicenter, Open-label, Single arm, Phase II Clinical Trial to Improve Sacituzumab Govitecan Tolerance in Patients with Metastatic Triple-Negative or Luminal Breast Cancer. – The PRIMED Study –

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

SAFE study: Stopping Antibiotics after 3 days for the treatment of FEbrile Neutropenia in Haematology patients, a randomized open-label non-inferiority trial

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Use of pegfilgrastim in severe chronic neutropenia

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients: efficacy and microbiologic safety.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Neutropenia trials by city

Neutropenia in Toronto Neutropenia in Vancouver Neutropenia in Montreal Neutropenia in Calgary Neutropenia in Edmonton Neutropenia in Ottawa Neutropenia in Winnipeg Neutropenia in Quebec City Neutropenia in Hamilton Neutropenia in Kitchener Neutropenia in London Neutropenia in Halifax Neutropenia in New York Neutropenia in Los Angeles Neutropenia in Chicago Neutropenia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease